ClinConnect ClinConnect Logo
Search / Trial NCT06239649

The Effect of RF Genicular Nerve Block Applied in the Preoperative Period on Fast-track Total Knee Arthroplasty

Launched by PAMUKKALE UNIVERSITY · Jan 25, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Fast Track Total Knee Arthroplasty Genicular Nerve Block Radiofrequency Ablation

ClinConnect Summary

This clinical trial is looking at a specific treatment called radiofrequency (RF) genicular nerve block, which is applied before knee surgery to see if it helps patients recover faster after total knee arthroplasty (TKA). The goal is to find out if this approach can reduce pain, improve function, and allow patients to go home sooner after their surgery. The study is currently recruiting participants aged between 40 and 85 who are scheduled for knee surgery due to osteoarthritis, a condition that causes pain and stiffness in the knee.

To be eligible for the trial, participants need to be able to understand and speak Turkish, and they should be having surgery on just one knee. However, people with certain health issues, such as previous major surgeries on the same leg, severe arthritis, or those with psychiatric disorders or other serious medical conditions, cannot participate. If you join the study, you can expect to receive detailed information about the trial, and you'll be closely monitored during your recovery to see how well the treatment works. This research could help improve care for future knee surgery patients.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Being between the ages of 40 and 85,
  • Being able to understand verbal and written information given in Turkish,
  • Being able to speak and understand Turkish,
  • Being subjected to unilateral TKA surgery due to the diagnosis of Primary Knee osteoarthritis
  • Exclusion Criteria:
  • Patients planned for revision knee prosthesis surgery,
  • Patients previously diagnosed with psychiatric disorders,
  • Patients who have undergone major surgery on the extremity where TKA will be applied,
  • Patients with comorbid diseases such as rheumatoid arthritis or cancer,
  • Patients with a score above 3 according to the American Society of Anesthesiologists (ASA) scoring,
  • Patients with neurological diseases that cause functional disability,
  • Patients with flexion limitation of more than 45 degrees and extension limitation of more than 20 degrees,
  • Patients who have to use hypnotic or anxiolytic drugs regularly,
  • Patients with alcohol or drug addiction,
  • Patients with bleeding disorders
  • Patients with uncontrolled diabetes

About Pamukkale University

Pamukkale University is a renowned academic institution located in Denizli, Turkey, dedicated to advancing medical research and education. As a clinical trial sponsor, the university leverages its extensive resources and expertise to facilitate innovative studies aimed at improving patient outcomes and contributing to the broader scientific community. With a commitment to ethical standards and regulatory compliance, Pamukkale University fosters collaboration among researchers, healthcare professionals, and industry partners, ensuring the rigorous execution of clinical trials that address critical health challenges. Through its research initiatives, the university aims to enhance the understanding of various medical conditions and support the development of effective therapies.

Locations

Denizli, Pamukkale, Turkey

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported